explore -WSS

explore

author：focus 2025-08-12 09:08:19 - browse：75

Scientist pipetting in a biotech lab -- biotech coverage from STAT — A researcher working in the lab at Crinetics Pharmaceuticals in San Diego. Courtesy Crinetics

SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego biotech a step closer to applying for Food and Drug Administration approval — and entry into a crowded market with blockbuster therapies sold by pharma giants.

In the Phase 3 study, dubbed PATHFNDR-1, nearly 60 patients were randomly assigned to receive a placebo or a daily dose of paltusotine, an oral medicine designed to lower levels of growth hormone, which is produced in excess by people with acromegaly. After 36 weeks of treatment, 25 of the 30 patients given the drug had growth-factor levels that were within the normal range compared to just 1 of 28 participants who took the placebo, a difference that was statistically significant. Researchers also found that the treatment’s side effects were mild overall.

Crinetics plans to file for FDA approval if it gets positive results from a second, ongoing Phase 3 trial of the drug in acromegaly patients. The biotech expects results from that study, known as PATHFNDR-2, by the first quarter of next year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Key Senate committee drafts bipartisan bill to stem drug shortages

focus

WSS

Diversity in clinical trials starts with building trust, experts say

People with mental disorders often marry others with same

H5N1 bird flu found in pasteurized milk: what we know

Pancreatic cancer is often deadly, but new discoveries are raising hope

Diversity in clinical trials starts with building trust, experts say

People with mental disorders often marry others with same

knowledge

explore

Wikipedia

Virginia high school admissions case could be legal follow

H5N1 bird flu virus started spreading in cows in Texas in December

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Getting Alzheimer's drug Leqembi to patients can be a challenge

Medicare proposal to cover medical devices draws a mixed reaction

Overprescribed: High cost isn't America's only drug problem

At least 13 dead in Texas as scorching temps continue

Medical bills so high, Medicare adding extra digits to claim forms

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why does health care cost so much? A reading guide

explore

Pancreatic cancer is often deadly, but new discoveries are raising hope

Health care needs a new profession: neuroimaging counseling

MassMutual is introducing free genetic testing for members

MultiPlan and major insurers sued for alleged medical price

Oral obesity drug from Viking Therapeutics hits key early target

Insurer loopholes limit power of law against surprise medical bills

leisure time

explore

focus

hotspot